Albert S. DeNittis MD, MS, joined Main Line Health in 2002. Before medical school he obtained his Master’s degree in cellular and developmental biology at Rutgers University. Dr. DeNittis then earned his medical degree from Rutgers-Robert Wood Johnson Medical, and subsequently, completed his residency training in radiation oncology at the Hospital of the University of Pennsylvania.
Dr. DeNittis also serves as chief of radiation oncology at Lankenau Medical Center, part of Main Line Health. Since joining the cancer team Dr. DeNittis has implemented a full service department built on current guidelines, safety and academics. He oversees the education and research programs in the department. He also is the principal investigator for the National Community Oncology Research Program (NCORP) of the Main Line Health system, one of 34 such programs in the country, and as such patients have access to them.
The radiation oncology department at Lankenau Medical Center has spearheaded many technological innovations. The newest addition is a state of the art new linear accelerator called the TrueBeam STx. This allows for stereotactic body irradiation (SBRT), and volume modulated arc therapy (VMAT) which allows for treatments in three to five days.
Dr. DeNittis also serves on many national committees through the NRG (nrgoncology.org). He serves on the NCORP steering, cancer prevention and control and membership committees. Recently in 2017 he was elected to the anal/rectal task force to the NCI. He is responsible for clinical trial development nationally. All of his efforts have led to an extensive list of publications, and over 100 presentations at national meetings. He has also coauthored seven book chapters, four of which have been Principles and Practice of Radiation Oncology, the specialties premier text book.
His achievements have earned him a clinical professor at the Lankenau Institute for Medical Research and he is a member of Thomas Jefferson University Cancer Center in Philadelphia. He is also a fellow in the College of Physicians of Philadelphia. Regionally he has been Philadelphia Top Doc for over seven years.
Dr. DeNittis is currently a season ticket holder to the Philadelphia Eagles, loves to travel as well as go to the New Jersey Shore.
- Gender: Male
- Language: English
Accepting New Patients
- Clinical Professor, Lankenau Institute for Medical Research
- Principal Investigator, Main Line Health/National Community Oncology Research Program (NCORP)
- Full member, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital
- Member, NCI Rectal/Anal Task Force
- Chief of Radiation Oncology, Lankenau Medical Center